---
layout: entry
title: "The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic"
link: "https://doi.org/10.3899/jrheum.200492"
author:
- Cron, Randy Q.; Chatham, W. Winn

summary:
- "123 pediatric rheumatology patients in Milan, Italy surveyed over a 7-week period from February 25 through April 14, 2020. None of the 123 patients on background biological disease modifying anti-rheumatic drug therapies had either confirmed or suspected Covid-19 (2). We appreciate our Italian colleagues' interest in our editorial denoting the role of the covid-19 panemic. It is encouraging that none of the patients on bDMARD therapies in Italy had either confirm or suspected."

original:
- "We appreciate our Italian colleagues' interest in our editorial denoting the rheumatologist's role in helping to diagnose and treat cytokine storm syndrome (CSS) in the setting of the Covid-19 panemic (1). It is encouraging that none of the 123 pediatric rheumatology patients (primarily juvenile idiopathic arthritis) on background biological disease modifying anti-rheumatic drug (bDMARD) therapies in Milan, Italy surveyed over a 7-week period from February 25 through April 14, 2020 (during which time Covid-19 was hyper-endemic there) had either confirmed or suspected Covid-19 (2)."
---

